Overview
- 39 inspections across 39 sites are on record.
- 193 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
39
Sites
39
Observations
193
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd | 24 Apr 2026 | Human Drugs | On file |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) | 15 Apr 2026 | Human Drugs | On file |
| MSD International GmbH (Singapore Branch) | 23 Jan 2026 | Human Drugs | On file |
| Matrix Pharmacorp Private Limited | 28 Nov 2025 | Human Drugs | On file |
| Shilpa Medicare Limited | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Jiangsu Hansoh Pharmaceutical Group Co., LtdLianyungang, China1 insp.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)Lianyungang, China1 insp.
MSD International GmbH (Singapore Branch)Singapore, Singapore1 insp.
Matrix Pharmacorp Private LimitedHyderabad, India1 insp.
Shilpa Medicare LimitedJadcherla, Mahabubnagar District, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Sandra A Hughes5 shared
Muna Algharibeh4 shared
Rowena S Nguyen3 shared
Joseph A Piechocki3 shared
Karen A Briggs2 shared
Jeffrey P Raimondi2 shared
Youkeun Kim2 shared
Hung H Do2 shared
Chad W Rice2 shared
Vaishali J Patel2 shared
Full investigator report
Get the verbatim findings behind Sandra A Boyd's 193 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site